Montis Biosciences

Location

leuven

Region

flanders

Stage

startup

Founded

2020

Status

active

Website

montisbio.com

Sector

biotech, medtech, deeptech

TLDR

Montis Biosciences is a biotechnology company developing dual-mechanism antibodies targeting complement C1q for neuroinflammatory and autoimmune diseases.

Overview

Montis Biosciences develops next-generation therapeutics that harness the dual biology of complement C1q by simultaneously targeting the complement and myeloid axes. The company's pipeline targets neuroinflammatory diseases, with a lead program in Guillain-Barré syndrome. Montis is headquartered in Leuven, Belgium, and is supported by investors including DROIA Ventures, Pfizer Ventures, Polaris Innovation Fund, ALSA Ventures and VIB.